Related references
Note: Only part of the references are listed.Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies
Mallory L. Myers et al.
NATURE COMMUNICATIONS (2023)
Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses
Eduard Puente-Massaguer et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2023)
Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice
Santosh Dhakal et al.
VACCINE (2022)
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
Carly M. Bliss et al.
MOLECULAR THERAPY (2022)
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial
Nicolas Folschweiller et al.
LANCET INFECTIOUS DISEASES (2022)
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
Xueyong Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses
Syed M. Moin et al.
IMMUNITY (2022)
An epitope-enriched immunogen expands responses to a conserved viral site
Timothy M. Caradonna et al.
CELL REPORTS (2022)
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
Meagan McMahon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Human infection of avian influenza A H3N8 virus and the viral origins: a descriptive study
Rengui Yang et al.
LANCET MICROBE (2022)
Next-Generation Influenza Vaccines
Masaru Kanekiyo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic
G. N. Okoli et al.
VACCINE (2021)
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model
Wen-Chun Liu et al.
VACCINES (2021)
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
Peter Richmond et al.
LANCET (2021)
Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase
Ericka Kirkpatrick Roubidoux et al.
MSPHERE (2021)
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update
Guan-Huei Lee et al.
EXPERT REVIEW OF VACCINES (2021)
A human infection case with avian-origin H10N3 influenza virus
Jisheng Jing et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2021)
Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
Yonghong Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
High Risk of Influenza Virus Infection Among Swine Workers: Examining a Dynamic Cohort in China
Laura K. Borkenhagen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Immunagenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I. Bernstein et al.
LANCET INFECTIOUS DISEASES (2020)
Influenza Vaccines Delivered in Early Childhood Could Turn Antigenic Sin into Antigenic Blessings
Michael Worobey et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn et al.
MOLECULAR THERAPY (2020)
The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus
Sankarasubramanian Rajaram et al.
VACCINE (2020)
H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model
Juan Manuel Carreno et al.
MBIO (2020)
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Tsun-Yung Kuo et al.
SCIENTIFIC REPORTS (2020)
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
Sandhya Bangaru et al.
CELL (2019)
Influenza Vaccine Effectiveness: Defining the H3N2 Problem
Edward A. Belongia et al.
CLINICAL INFECTIOUS DISEASES (2019)
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
Shuting Shi et al.
VACCINE (2019)
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
Felix Broecker et al.
NPJ VACCINES (2019)
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
Meagan McMahon et al.
FRONTIERS IN IMMUNOLOGY (2019)
Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice
Guha Asthagiri Arunkumar et al.
JOURNAL OF VIROLOGY (2019)
Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance
Yao-Qing Chen et al.
JOURNAL OF VIROLOGY (2019)
Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
Fatima Amanat et al.
EMERGING MICROBES & INFECTIONS (2019)
Characterization of swine-origin H1N1 canine influenza viruses
Guojun Wang et al.
EMERGING MICROBES & INFECTIONS (2019)
Is It Possible to Develop a Universal Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine
Florian Krammer et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Nextstrain: real-time tracking of pathogen evolution
James Hadfield et al.
BIOINFORMATICS (2018)
An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
Madhusudan Rajendran et al.
PLOS ONE (2018)
Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin
Irina Isakova-Sivak et al.
VIROLOGY (2018)
Immune responses after live attenuated influenza vaccination
Kristin G. -I. Mohn et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model
Daniel Stadlbauer et al.
EMERGING MICROBES & INFECTIONS (2018)
A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study
Raffael Nachbagauer et al.
VACCINES (2018)
Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model
Megan E. Ermler et al.
JOURNAL OF VIROLOGY (2017)
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
Madhusudan Rajendran et al.
MBIO (2017)
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
Raffael Nachbagauer et al.
NPJ VACCINES (2017)
Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China
Changwen Ke et al.
EMERGING INFECTIOUS DISEASES (2017)
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
Raffael Nachbagauer et al.
NATURE IMMUNOLOGY (2017)
Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses
Richard A. Neher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting
Katelyn M. Gostic et al.
SCIENCE (2016)
Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
Raffael Nachbagauer et al.
MBIO (2016)
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
Raffael Nachbagauer et al.
NPJ VACCINES (2016)
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
Arnold S. Monto et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hadi M. Yassine et al.
NATURE MEDICINE (2015)
An H1ON8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13
Teddy John Wohlbold et al.
VACCINE (2015)
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
MBIO (2015)
Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model
Irina Isakova-Sivak et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain
Dirk Eggink et al.
JOURNAL OF VIROLOGY (2014)
Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection : a descriptive study
HaiYing Chen et al.
LANCET (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
I. Margine et al.
JOURNAL OF VIROLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
Rong Hai et al.
JOURNAL OF VIROLOGY (2012)
Positive selection for gains of N-linked glycosylation sites in hemagglutinin during evolution of H3N2 human influenza A virus
Yoshiyuki Suzuki
GENES & GENETIC SYSTEMS (2011)
A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains
Rong Hai et al.
JOURNAL OF VIROLOGY (2011)
The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses
Natalie Pica et al.
JOURNAL OF VIROLOGY (2011)
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
Fabian Sievers et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
Taia T. Wang et al.
PLOS PATHOGENS (2010)
Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses
Bao-Zhong Wang et al.
JOURNAL OF VIROLOGY (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells
Sunil Kannanganat et al.
JOURNAL OF VIROLOGY (2007)
Functional signatures of protective antiviral T-cell immunity in human virus infections
Alexandre Harari et al.
IMMUNOLOGICAL REVIEWS (2006)
Share Paper
